{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:24:29Z","timestamp":1791944669569,"version":"4.3.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["JAHA"],"published-print":{"date-parts":[[2019,11,5]]},"abstract":"<jats:sec xml:lang=\"en\">\n            <jats:title>Background<\/jats:title>\n            <jats:p xml:lang=\"en\">\n              Early discontinuation of P2Y\n              <jats:sub>12<\/jats:sub>\n              antagonists post\u2013percutaneous coronary intervention may increase risk of stent thrombosis or nonstent recurrent myocardial infarction. Our aims were to (1) analyze the early discontinuation rate of P2Y\n              <jats:sub>12<\/jats:sub>\n              antagonists post\u2013percutaneous coronary intervention, (2) explore factors associated with early discontinuation, and (3) analyze the risk of major adverse cardiovascular events (death, acute coronary syndrome, revascularization, or stroke) associated with discontinuation from a prespecified prescribing instruction of 1\u00a0year.\n            <\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Method and Results<\/jats:title>\n            <jats:p xml:lang=\"en\">We studied 2090 patients (2011\u20132015) who were recommended for clopidogrel for 12\u00a0months (+aspirin) post\u2013percutaneous coronary intervention within a retrospective observational population cohort. Relationships between clopidogrel discontinuation and major adverse cardiac events were evaluated over 18\u2010month follow\u2010up. Discontinuation of clopidogrel in the first 4 quarters was low at 1.1%, 2.6%, 3.7%, and 6.1%, respectively. Previous revascularization, previous ischemic stroke, and age &gt;80\u00a0years were independent predictors of early discontinuation. In a time\u2010dependent multiple regression model, clopidogrel discontinuation and bleeding (hazard ratio=1.82 [1.01\u20133.30] and hazard ratio=5.30 [3.14\u20138.94], respectively) were independent predictors of major adverse cardiac events as were age &lt;49 and \u226570\u00a0years (versus those aged 50\u201359\u00a0years), hypertension, chronic kidney disease stage 4+, previous revascularization, ischemic stroke, and thromboembolism. Furthermore, in those with both bleeding and clopidogrel discontinuation, hazard ratio for major adverse cardiac events was 9.34 (3.39\u201325.70).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec xml:lang=\"en\">\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p xml:lang=\"en\">Discontinuation of clopidogrel is low in the first year post\u2013percutaneous coronary intervention, where a clear discharge instruction to treat for 1\u00a0year is provided. Whereas this is reassuring from the population level, at an individual level discontinuation earlier than the intended duration is associated with an increased rate of adverse events, most notably in those with both bleeding and discontinuation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1161\/jaha.119.012812","type":"journal-article","created":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T09:02:14Z","timestamp":1572339734000},"update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Early Discontinuation of P2Y\n            <sub>12<\/sub>\n            Antagonists and Adverse Clinical Events Post\u2013Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort"],"prefix":"10.1161","volume":"8","author":[{"given":"Daniel E.","family":"Harris","sequence":"first","affiliation":[{"name":"Swansea University Medical School Swansea UK"},{"name":"Swansea Bay University Health Board Swansea UK"},{"name":"HDR UK Wales &amp; Northern Ireland Swansea University Swansea UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arron","family":"Lacey","sequence":"additional","affiliation":[{"name":"Swansea University Medical School Swansea UK"},{"name":"HDR UK Wales &amp; Northern Ireland Swansea University Swansea UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Akbari","sequence":"additional","affiliation":[{"name":"Swansea University Medical School Swansea UK"},{"name":"HDR UK Wales &amp; Northern Ireland Swansea University Swansea UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Obaid","sequence":"additional","affiliation":[{"name":"Swansea University Medical School Swansea UK"},{"name":"Swansea Bay University Health Board Swansea UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave A.","family":"Smith","sequence":"additional","affiliation":[{"name":"Swansea Bay University Health Board Swansea UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraint H.","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Swansea Bay University Health Board Swansea UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Barry","sequence":"additional","affiliation":[{"name":"Swansea Bay University Health Board Swansea UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike B.","family":"Gravenor","sequence":"additional","affiliation":[{"name":"Swansea University Medical School Swansea UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian P.","family":"Halcox","sequence":"additional","affiliation":[{"name":"Swansea University Medical School Swansea UK"},{"name":"Swansea Bay University Health Board Swansea UK"},{"name":"HDR UK Wales &amp; Northern Ireland Swansea University Swansea UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.740324"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904327"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000404"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx419"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000669"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.109.902031"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr340"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-14-100"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.618066"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.17.2126"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000127105.99982.21"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.2.joc60179"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2018-313148"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61720-1"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-9-3"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-9-157"},{"key":"e_1_3_2_19_2","unstructured":"SAIL Databank . Primary care GP dataset. Available at: https:\/\/saildatabank.com\/saildata\/sail-datasets\/primary-care-gp-dataset\/. Accessed October 11 2018."},{"key":"e_1_3_2_20_2","unstructured":"Welsh Demographic Services. Available at: http:\/\/www.wales.nhs.uk\/nwis\/page\/52552. Accessed October 11 2018."},{"key":"e_1_3_2_21_2","unstructured":"Stats Wales. Available at: https:\/\/statswales.gov.wales\/Catalogue\/Community-Safety-and-Social-Inclusion\/Welsh-Index-of-Multiple-Deprivation\/Archive\/WIMD-2011. Accessed October 11 2018."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903156087"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.271"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr422"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.06.056"}],"container-title":["Journal of the American Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/JAHA.119.012812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:31:33Z","timestamp":1715599893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/JAHA.119.012812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":24,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2019,11,5]]}},"alternative-id":["10.1161\/JAHA.119.012812"],"URL":"https:\/\/doi.org\/10.1161\/jaha.119.012812","relation":{},"ISSN":["2047-9980"],"issn-type":[{"value":"2047-9980","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]},"assertion":[{"value":"2019-04-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e012812"}}